Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

35.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 373,908
  • Market Cap: £126.52m

Latest ShareCast News

Creo device used in 'groundbreaking' lung cancer procedure

By Josh White

Date: Friday 01 Mar 2024

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

Creo Medical FY revenues up double digits

By Iain Gilbert

Date: Wednesday 07 Feb 2024

(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.

Creo launches 'Speedboat Ultraslim' with first UK procedure

By Josh White

Date: Wednesday 13 Dec 2023

(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 35.00p
Change Today -0.25p
% Change -0.71 %
52 Week High 48.10
52 Week Low 23.25
Volume 373,908
Shares Issued 361.48m
Market Cap £126.52m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
8.41% above the market average8.41% above the market average8.41% above the market average8.41% above the market average8.41% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Income Not Available
Growth
43.57% above the market average43.57% above the market average43.57% above the market average43.57% above the market average43.57% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:31 100,000 @ 34.63p
16:27 56,000 @ 35.48p
16:20 530 @ 35.45p
16:11 200 @ 35.45p
16:08 1,408 @ 35.50p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page